ADC Contract Manufacturing market Growth Opportunity and Industry Forecast to 2035

Roots Analysis has announced the addition of “ADC Contract Manufacturing Market (5th Edition), 2022-2035” report to its list of offerings.

Key Market Insights

• A number of players currently claim to have the required capabilities to offer contract manufacturing / conjugation services for antibody drug conjugates, worldwide
• A significant portion of agreements signed in recent years are focused on product development and manufacturing; multiple large-sized firms have also signed agreements pertaining to ADCs
• In order to meet the rising demand for ADC therapeutics, CMOs have made elaborate investments to expand their capacities, primarily for clinical purposes; this trend is most pronounced in the US and Switzerland
• More than 80 ADC therapeutic developers were evaluated as strategic partners to forge manufacturing alliances with contract service providers, to further enhance their capabilities within the domain
• In 2035, close to 50% of the demand for ADC therapeutics is likely to be generated in North America; further, a sizeable proportion of the current demand is generated by commercialized therapeutics
• In the past few years, several new clinical trials have been registered; around 85% of such studies are evaluating candidates in early stages of development
• The installed global contract manufacturing capacity for ADCs is well distributed across different geographies; large players account for 90% of the total capacity
• The installed capacity is sufficient to meet the current overall annual demand; however, as the demand rises, CMOs will be required to invest in installing incremental capacity
• With over 70% of the ADC manufacturing operations currently being outsourced, we expect the market to grow at an annualized rate of over 12% over the next decade
• The anticipated opportunity is expected to be segregated across a variety of linkers and antibodies; it is also likely to be well-distributed across the key geographical regions

Table of Contents

1.                     PREFACE

1.1.                  Scope of the Report

1.2.                  Research Methodology

1.3.                  Key Questions Answered

1.4                   Chapter Outlines

2.                     EXECUTIVE SUMMARY

3.                     INTRODUCTION

3.1.                  Chapter Overview

3.2.                  Key Components of Antibody Drug Conjugates (ADCs)

3.3.               ADC Manufacturing

3.4.               Challenges Associated with Supply Chain and Method Transfer

3.6.               Future Perspective

4.                  ADC CONTRACT MANUFACTURING SERVICE PROVIDERS: MARKET LANDSCAPE

4.1.               Chapter Overview

4.2.               ADC Contract Manufacturing Service Providers: Overall Market Landscape

4.3.               List of Antibody Contract Manufacturing Service Providers

4.4.               List of HPAPI / Cytotoxic Payload Contract Manufacturing Service Providers

4.5.               List of Biologics Fill / Finish Service Providers

5.                  COMPANY PROFILES

5.1.               Chapter Overview

5.2.               MabPlex

5.2.1.            Company Overview

5.2.2.            ADC Offerings

5.2.3.            Manufacturing Facilities

5.2.4.            Recent Development and Future Outlook

5.3.               AbbVie Contract Manufacturing

5.4.               Lonza

5.5.               Catalent Pharma Solutions

5.6.               Goodwin Biotechnology

5.8.               Millipore Sigma

5.9.               Abzena

5.10.             CARBOGEN AMCIS

5.11.             WuXi Biologics

5.12.             Cerbios-Pharma

5.13.             Formosa Laboratories

5.14.             Creative Biolabs

5.15.             Novasep

5.16.             Sterling Pharma Solutions

6.                  COMPANY COMPETITIVENESS ANALYSIS

6.1.               Chapter Overview

6.2.               Methodology and Key Parameters

6.3.               ADC Contract Manufacturing Service Providers: Company Competitiveness Analysis

7.                  ADC CONTRACT MANUFACTURING SERVICE PROVIDERS: RECENT EXPANSIONS

7.1.               Chapter Overview

7.2.               ADC Contract Manufacturing Service Providers: Recent Expansions

8.                  ADC CONTRACT MANUFACTURING SERVICE PROVIDERS: PARTNERSHIPS AND COLLABORATIONS

8.1.               Chapter Overview

8.2.               Partnership Models

8.3.               ADC Contract Manufacturing Service Providers: List of Partnerships and Collaborations

9.                  MAKE VERSUS BUY DECISION MAKING

9.1.               Chapter Overview

9.2.               Assumptions and Key Parameters

9.3.               Concluding Remarks

10.                VALUE CHAIN ANALYSIS

10.1.             Chapter Overview

10.2.             ADC Development Value Chain

10.3.             Cost Distribution Across the Value Chain

11.                   ADC MANUFACTURING: CAPACITY ANALYSIS

11.1.                Chapter Overview

11.2.                Key Assumptions and Methodology

11.3.                ADC Manufacturing: Global Installed Capacity

12.                   ADC THERAPEUTICS: MARKET OVERVIEW

12.1.                Chapter Overview

12.2.                List of ADC Therapeutics

12.3.                Antibody Drug Conjugates: List of Therapy Developers

13.                   NOVEL ADC CONJUGATION TECHNOLOGY PLATFORMS

13.1.                Chapter Overview

13.2.                First Generation ADC Technologies

13.3.                Second Generation ADC Technologies

13.4.                Third Generation ADC Technologies

13.5.                Other Emerging ADC Technologies

13.6.                Evolutionary Analysis

14.                   CLINICAL TRIALS ANALYSIS

14.1.                Chapter Overview

14.2.                Scope and Methodology

14.3.                ADC Therapeutics: Clinical Trial Analysis

14.4.                ADC Therapeutics: Analysis by Antibody Isotope and Geography

14.5.                ADC Therapeutics: Analysis by Type of Payload and Geography

14.6.                ADC Therapeutics: Analysis by Type of Linker and Geography

15.                   LIKELY PARTNER ANALYSIS

15.1.                Chapter Overview

15.2.                Scope and Methodology

15.3.                Key Potential Strategic Partners for ADC Therapeutics Developers

16.                   ADC THERAPEUTICS: DEMAND ANALYSIS

16.1.                Chapter Overview

16.2.                Key Assumptions and Methodology

16.3.                ADC Therapeutics: Overall Annual Demand

16.4.                ADC Therapeutics: Demand and Supply Analysis

17.                   REGIONAL CAPABILITY ASSESSMENT ANALYSIS

17.1.                Chapter Overview

17.2.                Assumptions and Key Parameters

17.3.                Regional Capability Assessment in North America

17.4.                Regional Capability Assessment in Europe

17.5.                Regional Capability Assessment in Asia-Pacific

18.                   ATTRACTIVENESS COMPETETIVENESS MATRIX

18.1.                Chapter Overview

18.2.                AC Matrix: Overview

18.3.                Analytical Methodology

18.4.                AC Matrix: ADC Contract Manufacturing Scenario for Type of Service(s) Offered, 2022-2028

18.5.                AC Matrix: ADC Contract Manufacturing Scenario for Type of Service(s) Offered, 2029-2035

18.6.                AC Matrix: ADC Contract Manufacturing Scenario for Key Geographies, 2022-2028

18.7.                AC Matrix: ADC Contract Manufacturing Scenario for Key Geographies, 2029-2035

19.                   MARKET SIZING AND OPPORTUNITY ANALYSIS

19.1.                Chapter Overview

19.2.                Forecast Methodology

19.3.                Global ADC Therapeutics Market, 2022-2035

19.4.                Input Data and Key Assumptions

19.5.                Global ADC Contract Manufacturing Market, 2022-2035

19.6.                ADC Contract Manufacturing Market for Commercial Products, 2022-2035

19.7.                ADC Contract Manufacturing Market for Clinical Products, 2022-2035

20.                   SWOT ANALYSIS

20.1.                Chapter Overview

20.2.                Strengths

20.3.                Weaknesses

20.4.                Opportunities

20.5.                Threats

20.6.                Comparison of SWOT Factors

21.                   CONCLUDING REMARKS

22.                   INTERVIEW TRANSCRIPTS

22.1.                Chapter Overview

22.2.                BSP Pharmaceuticals

22.3.                Oxford BioTherapeutics

22.4.                Abzena

22.5.                Syndivia

22.6.                Cerbios-Pharma           

22.7.                NBE-Therapeutics

22.8.                Eisai

22.9.                Synaffix

22.10.              Pierre Fabre

22.11.              Goodwin Biotechnology

22.12.              Cerbios-Pharma

22.13.              Catalent Pharma Solutions

22.14.              Lonza

22.15.              Piramal Pharma Solutions

22.16.              Ajinomoto Bio-Pharma Services

22.17.              Interview Transcript: Anonymous (Director, Business Development, Leading CMO)

22.18.              Interview Transcript: Anonymous (Chief Executive Officer, Leading CMO)

23.                   APPENDIX I: TABULATED DATA

24.                   APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/view_document/adc-contract-manufacturing-market/218.html

You may also be interested in the following titles:

Global Antibiotics Market

Pharmaceutical Polymers / Medical Polymers Market

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

Exclusive For You!

🚀 Ready to take your business to the next level? Look no further than Walltronix! We're your go-to experts for all things digital, dedicated to helping businesses of all sizes thrive. 🌟 Imagine a future where innovation and creativity reign supreme. That's what we're all about. 🎨 From jaw-dropping design and development to turbocharged SEO services, we've got your digital needs covered. 💻✨ Join us on this exciting journey to digital success! 🌐💼
Walltronix core services encompass:

• Digital & Social Media Marketing
• Website Design & Development
• E-commerce Development
• Native Mobile Applications
• Web & SaaS Applications
• SEO & Backlink Generation
• Content Management
• Blog creation & monetization

Unlocking Your Potential with Walltronix:
Discover a range of Free invaluable tools, thoughtfully crafted to enhance your digital journey:

1. Bolt: Website audit & SEO report generator Tool
2. The SMS City: Premium WhatsApp & SMS messaging Platform
3. Sizzly: Advanced URL shortner, Custom CTA, Bio Pages & much More
4. Optimus: Track live website visitors & traffic
5. Mosh: Ultimate website widgets & conversion generator

Elevate your digital presence and engage your audience effectively with Walltronix. Join hands with us, and let's shape your digital future together.
Visit Website
Mail Us
WhatsApp Us
Our Portfolios